Cargando…
MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway
Mucin 3A (MUC3A) is overexpressed in colorectal cancer (CRC) and associated with poor prognosis, but the related mechanism remains unclear. Our study found that MUC3A promotes the progression of CRC by activating the PI3K/Akt/mTOR signaling pathway. Knockout of MUC3A significantly inhibited the prol...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161576/ https://www.ncbi.nlm.nih.gov/pubmed/35655161 http://dx.doi.org/10.1186/s12885-022-09709-8 |
_version_ | 1784719514983727104 |
---|---|
author | Su, Wei Feng, Baijie Hu, Lina Guo, Xianzhi Yu, Minghua |
author_facet | Su, Wei Feng, Baijie Hu, Lina Guo, Xianzhi Yu, Minghua |
author_sort | Su, Wei |
collection | PubMed |
description | Mucin 3A (MUC3A) is overexpressed in colorectal cancer (CRC) and associated with poor prognosis, but the related mechanism remains unclear. Our study found that MUC3A promotes the progression of CRC by activating the PI3K/Akt/mTOR signaling pathway. Knockout of MUC3A significantly inhibited the proliferation of CRC cells and induced G1 phase arrest by upregulating p21 protein, an important cell cycle regulator. Moreover, knockout of MUC3A significantly inhibited invasion ability and enhanced the sensitivity to the chemotherapeutic agent 5-FU. Furthermore, we found that knockout of MUC3A repressed the PI3K/Akt/mTOR pathway through RNA-seq. Treatment with the PI3K/Akt/mTOR pathway inhibitor rapamycin successfully eliminated the difference in proliferation, invasion and chemoresistance between MUC3A knockout cells and control cells. Our study suggests that MUC3A is a potential oncogene that promotes the proliferation, invasion, and chemotherapy resistance of CRC. Moreover, CRC patients with high expression of MUC3A may benefit from rapamycin treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09709-8. |
format | Online Article Text |
id | pubmed-9161576 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91615762022-06-03 MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway Su, Wei Feng, Baijie Hu, Lina Guo, Xianzhi Yu, Minghua BMC Cancer Research Mucin 3A (MUC3A) is overexpressed in colorectal cancer (CRC) and associated with poor prognosis, but the related mechanism remains unclear. Our study found that MUC3A promotes the progression of CRC by activating the PI3K/Akt/mTOR signaling pathway. Knockout of MUC3A significantly inhibited the proliferation of CRC cells and induced G1 phase arrest by upregulating p21 protein, an important cell cycle regulator. Moreover, knockout of MUC3A significantly inhibited invasion ability and enhanced the sensitivity to the chemotherapeutic agent 5-FU. Furthermore, we found that knockout of MUC3A repressed the PI3K/Akt/mTOR pathway through RNA-seq. Treatment with the PI3K/Akt/mTOR pathway inhibitor rapamycin successfully eliminated the difference in proliferation, invasion and chemoresistance between MUC3A knockout cells and control cells. Our study suggests that MUC3A is a potential oncogene that promotes the proliferation, invasion, and chemotherapy resistance of CRC. Moreover, CRC patients with high expression of MUC3A may benefit from rapamycin treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09709-8. BioMed Central 2022-06-02 /pmc/articles/PMC9161576/ /pubmed/35655161 http://dx.doi.org/10.1186/s12885-022-09709-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Su, Wei Feng, Baijie Hu, Lina Guo, Xianzhi Yu, Minghua MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway |
title | MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway |
title_full | MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway |
title_fullStr | MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway |
title_full_unstemmed | MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway |
title_short | MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway |
title_sort | muc3a promotes the progression of colorectal cancer through the pi3k/akt/mtor pathway |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161576/ https://www.ncbi.nlm.nih.gov/pubmed/35655161 http://dx.doi.org/10.1186/s12885-022-09709-8 |
work_keys_str_mv | AT suwei muc3apromotestheprogressionofcolorectalcancerthroughthepi3kaktmtorpathway AT fengbaijie muc3apromotestheprogressionofcolorectalcancerthroughthepi3kaktmtorpathway AT hulina muc3apromotestheprogressionofcolorectalcancerthroughthepi3kaktmtorpathway AT guoxianzhi muc3apromotestheprogressionofcolorectalcancerthroughthepi3kaktmtorpathway AT yuminghua muc3apromotestheprogressionofcolorectalcancerthroughthepi3kaktmtorpathway |